Diabetes, Vol 46, Issue 3 508-512, Copyright © 1997 by American Diabetes Association

ARTICLES

Amino acid polymorphisms in the ATP-regulatable inward rectifier Kir6.2 and their relationships to glucose- and tolbutamide-induced insulin secretion, the insulin sensitivity index, and NIDDM

L Hansen, SM Echwald, T Hansen, SA Urhammer, JO Clausen and O Pedersen
Steno Diabetes Center and the Hagedorn Research Institute, Glostrup University Hospital, Copenhagen, Denmark.

Kir6.2 is an inwardly rectifying potassium channel that is expressed in pancreatic beta-cells and cardiac and skeletal muscle. Expressed together with the high-affinity sulphonylurea receptor, it reconstitutes a sulphonylurea- and also ATP-sensitive potassium channel resembling the native beta-cell channel. The objective of this study was to search for mutations in the Kir6.2 gene that might be associated with NIDDM or related to altered insulin secretion, insulin action, or glucose metabolism in healthy subjects. Using polymerase chain reaction-single-strand conformation polymorphism analysis (PCR-SSCP) on genomic DNA from 69 Danish NIDDM patients and 66 matched control subjects, we report the finding of three missense polymorphisms in otherwise conserved codons and three silent polymorphisms in the gene encoding Kir6.2: codon 23 (GAG/AAG), Glu-->Lys; codon 190 (GCT/GCC), Ala-->Ala; codon 267 (CTC/CTG), Leu-->Leu; codon 270 (CTG/GTG), Leu-->Val; codon 337 (ATC/GTC), Ile-->Val; codon 381 (AAG/AAA), Lys-->Lys. The codon 23 and codon 337 amino acid polymorphisms were always coupled. The allelic frequencies of the polymorphisms were similar in NIDDM patients and control subjects. The amino acid polymorphisms were not associated with altered insulin secretion after intravenous glucose or tolbutamide injections or with altered glucose effectiveness in a phenotype study of 346 young healthy subjects. However, carriers of the maximal load of amino acid variants, the compound homozygous codon 23/337 and heterozygous codon 270, had on average a 62% higher insulin sensitivity index (P = 0.006), compared with noncarriers. We conclude that a combination of common Kir6.2 amino acid variants may contribute to the genetic background behind the large variation of the insulin sensitivity index in the general population.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Doi, M. Kubo, T. Ninomiya, K. Yonemoto, M. Iwase, H. Arima, J. Hata, Y. Tanizaki, M. Iida, and Y. Kiyohara Impact of Kir6.2 E23K Polymorphism on the Development of Type 2 Diabetes in a General Japanese Population: The Hisayama Study Diabetes, November 1, 2007; 56(11): 2829 - 2833. [Abstract] [Full Text] [PDF]

				E. R. Pearson, L. A. Donnelly, C. Kimber, A. Whitley, A. S.F. Doney, M. I. McCarthy, A. T. Hattersley, A. D. Morris, and C. N.A. Palmer Variation in TCF7L2 Influences Therapeutic Response to Sulfonylureas: A GoDARTs Study Diabetes, August 1, 2007; 56(8): 2178 - 2182. [Abstract] [Full Text] [PDF]

				N. Yokoi, M. Kanamori, Y. Horikawa, J. Takeda, T. Sanke, H. Furuta, K. Nanjo, H. Mori, M. Kasuga, K. Hara, et al. Association Studies of Variants in the Genes Involved in Pancreatic {beta}-Cell Function in Type 2 Diabetes in Japanese Subjects. Diabetes, August 1, 2006; 55(8): 2379 - 2386. [Abstract] [Full Text] [PDF]

				G. Sesti, E. Laratta, M. Cardellini, F. Andreozzi, S. Del Guerra, C. Irace, A. Gnasso, M. Grupillo, R. Lauro, M. L. Hribal, et al. The E23K Variant of KCNJ11 Encoding the Pancreatic {beta}-Cell Adenosine 5'-Triphosphate-Sensitive Potassium Channel Subunit Kir6.2 Is Associated with an Increased Risk of Secondary Failure to Sulfonylurea in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2334 - 2339. [Abstract] [Full Text] [PDF]

				T. Yorifuji, K. Nagashima, K. Kurokawa, M. Kawai, M. Oishi, Y. Akazawa, M. Hosokawa, Y. Yamada, N. Inagaki, and T. Nakahata The C42R Mutation in the Kir6.2 (KCNJ11) Gene as a Cause of Transient Neonatal Diabetes, Childhood Diabetes, or Later-Onset, Apparently Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3174 - 3178. [Abstract] [Full Text] [PDF]

				S. K. Hansen, E.-M. D. Nielsen, J. Ek, G. Andersen, C. Glumer, B. Carstensen, P. Mouritzen, T. Drivsholm, K. Borch-Johnsen, T. Jorgensen, et al. Analysis of Separate and Combined Effects of Common Variation in KCNJ11 and PPARG on Risk of Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3629 - 3637. [Abstract] [Full Text] [PDF]

				J. C. Florez, N. Burtt, P. I.W. de Bakker, P. Almgren, T. Tuomi, J. Holmkvist, D. Gaudet, T. J. Hudson, S. F. Schaffner, M. J. Daly, et al. Haplotype Structure and Genotype-Phenotype Correlations of the Sulfonylurea Receptor and the Islet ATP-Sensitive Potassium Channel Gene Region Diabetes, May 1, 2004; 53(5): 1360 - 1368. [Abstract] [Full Text] [PDF]

				M. J. Riedel, P. Boora, D. Steckley, G. de Vries, and P. E. Light Kir6.2 Polymorphisms Sensitize {beta}-Cell ATP-Sensitive Potassium Channels to Activation by Acyl CoAs: A Possible Cellular Mechanism for Increased Susceptibility to Type 2 Diabetes? Diabetes, October 1, 2003; 52(10): 2630 - 2635. [Abstract] [Full Text] [PDF]

				A. L. Gloyn, M. N. Weedon, K. R. Owen, M. J. Turner, B. A. Knight, G. Hitman, M. Walker, J. C. Levy, M. Sampson, S. Halford, et al. Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic {beta}-Cell KATP Channel Subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) Confirm That the KCNJ11 E23K Variant Is Associated With Type 2 Diabetes Diabetes, February 1, 2003; 52(2): 568 - 572. [Abstract] [Full Text] [PDF]

				E.-M. D. Nielsen, L. Hansen, B. Carstensen, S. M. Echwald, T. Drivsholm, C. Glumer, B. Thorsteinsson, K. Borch-Johnsen, T. Hansen, and O. Pedersen The E23K Variant of Kir6.2 Associates With Impaired Post-OGTT Serum Insulin Response and Increased Risk of Type 2 Diabetes Diabetes, February 1, 2003; 52(2): 573 - 577. [Abstract] [Full Text] [PDF]

				C. Schwanstecher and M. Schwanstecher Nucleotide Sensitivity of Pancreatic ATP-Sensitive Potassium Channels and Type 2 Diabetes Diabetes, December 1, 2002; 51(90003): S358 - 362. [Abstract] [Full Text] [PDF]

				C. Schwanstecher, B. Neugebauer, M. Schulz, and M. Schwanstecher The Common Single Nucleotide Polymorphism E23K in KIR6.2 Sensitizes Pancreatic {beta}-Cell ATP-Sensitive Potassium Channels Toward Activation Through Nucleoside Diphosphates Diabetes, December 1, 2002; 51(90003): S363 - 367. [Abstract] [Full Text] [PDF]

				H. Huopio, J. Jaaskelainen, J. Komulainen, R. Miettinen, P. Karkkainen, M. Laakso, P. Tapanainen, R. Voutilainen, and T. Otonkoski Acute Insulin Response Tests for the Differential Diagnosis of Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4502 - 4507. [Abstract] [Full Text] [PDF]

				L. M. 't Hart, T. W. van Haeften, J. M. Dekker, M. Bot, R. J. Heine, and J. A. Maassen Variations in Insulin Secretion in Carriers of the E23K Variant in the KIR6.2 Subunit of the ATP-Sensitive K+ Channel in the {beta}-Cell Diabetes, October 1, 2002; 51(10): 3135 - 3138. [Abstract] [Full Text] [PDF]

				C. G. Nichols and J. C. Koster Diabetes and insulin secretion: whither KATP? Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E403 - E412. [Abstract] [Full Text] [PDF]

				O. Tschritter, M. Stumvoll, F. Machicao, M. Holzwarth, M. Weisser, E. Maerker, A. Teigeler, H. Haring, and A. Fritsche The Prevalent Glu23Lys Polymorphism in the Potassium Inward Rectifier 6.2 (KIR6.2) Gene Is Associated With Impaired Glucagon Suppression in Response to Hyperglycemia Diabetes, September 1, 2002; 51(9): 2854 - 2860. [Abstract] [Full Text] [PDF]

				C. Schwanstecher, U. Meyer, and M. Schwanstecher KIR6.2 Polymorphism Predisposes to Type 2 Diabetes by Inducing Overactivity of Pancreatic {beta}-Cell ATP-Sensitive K+ Channels Diabetes, March 1, 2002; 51(3): 875 - 879. [Abstract] [Full Text] [PDF]

				S. C. Elbein, J. Sun, E. Scroggin, K. Teng, and S. J. Hasstedt Role of Common Sequence Variants in Insulin Secretion in Familial Type 2 Diabetic Kindreds: The sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1{alpha} genes Diabetes Care, March 1, 2001; 24(3): 472 - 478. [Abstract] [Full Text]

				M. S. Djurhuus, A. Vaag, and N. A. H. Klitgaard Muscle Sodium, Potassium, and [3H]Ouabain Binding in Identical Twins, Discordant for Type 2 Diabetes J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 859 - 866. [Abstract] [Full Text]

				L. Hansen, S. Urioste, H. V. Petersen, J. N. Jensen, H. Eiberg, F. Barbetti, P. Serup, T. Hansen, and O. Pedersen Missense Mutations in the Human Insulin Promoter Factor-1 Gene and Their Relation to Maturity-Onset Diabetes of the Young and Late-Onset Type 2 Diabetes Mellitus in Caucasians J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1323 - 1326. [Abstract] [Full Text]

				F. J. Service, N. Natt, G. B. Thompson, C. S. Grant, J. A. van Heerden, J. C. Andrews, E. Lorenz, A. Terzic, and R. V. Lloyd Noninsulinoma Pancreatogenous Hypoglycemia: A Novel Syndrome of Hyperinsulinemic Hypoglycemia in Adults Independent of Mutations in Kir6.2 and SUR1 Genes J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1582 - 1589. [Abstract] [Full Text]